Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value ($000): $179,342 (100.0% shares, 0.0% debt)

Holdings (7)

MDXG MIMEDX GROUP, INC. 36.3%

Value ($000) $65,095 Shares 23,415,584 Est. Cost $7.34 Unrealized -59.3%

TELA TELA BIO, INC. 26.4%

Value ($000) $47,273 Shares 4,110,709 Est. Cost $11.82 Unrealized -24.2%

BVS BIOVENTUS 17.6%

Value ($000) $31,572 Shares 12,096,702 Est. Cost $14.24 Unrealized -69.3%

EYPT EYEPOINT PHARMACEUTICALS INC 8.2%

Value ($000) $14,668 Shares 4,190,921 Est. Cost $4.68 Unrealized -5.7%

— VENUS CONCEPT, INC. 5.6%

Value ($000) $10,028 Shares 31,337,856 Est. Cost $2.12 Unrealized —

— REVANCE THERAPEUTICS INC 4.7%

Value ($000) $8,438 Shares 457,085 Est. Cost $31.50 Unrealized —

MNOV MEDICINOVA INC 1.3%

Value ($000) $2,267 Shares 1,105,941 Est. Cost $2.95 Unrealized -25.1%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MDXG	MIMEDX GROUP, INC.	23,415,584	$65,095	36.3%	$7.34	-59.3%	COM	602496101
TELA	TELA BIO, INC.	4,110,709	$47,273	26.4%	$11.82	-24.2%	COM	872381108
BVS	BIOVENTUS	12,096,702	$31,572	17.6%	$14.24	-69.3%	COM CL A	09075A108
EYPT	EYEPOINT PHARMACEUTICALS INC	4,190,921	$14,668	8.2%	$4.68	-5.7%	COM NEW	30233G209
—	VENUS CONCEPT, INC.	31,337,856	$10,028	5.6%	$2.12	—	COM	92332W105
—	REVANCE THERAPEUTICS INC	457,085	$8,438	4.7%	$31.50	—	COM	761330109
MNOV	MEDICINOVA INC	1,105,941	$2,267	1.3%	$2.95	-25.1%	COM NEW	58468P206